Carlos Ruíz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Carlos Ruíz has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Aymée Robainas Barcia
Laboratorio Reig Jofre, 08970 Sant Joan Despí, Spain
3 shared publications - Carles Nieto
Laboratorio Reig Jofre S.A., Gran Capità, 10, Sant Joan Despí, 08970 Barcelona, Spain
3 shared publications - Aurora Guerra-Tapia
Universidad Complutense de Madrid, Facultad de Medicina, Madrid, Spain
2 shared publications - Ester Moreno
Hospital Galdakao, Barrio Labeaga, s/n, 48960 Galdakao, Spain
2 shared publications - Helena Martínez
Laboratorio Reig Jofre S.A., Gran Capità, 10, Sant Joan Despí, 08970 Barcelona, Spain
2 shared publications - Laia Montell
Laboratorio Reig Jofre S.A., Gran Capità, 10, Sant Joan Despí, 08970 Barcelona, Spain
2 shared publications
Latest Publications
- Open Access
- 18 April 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (4) , 915
Shotgun Metagenomic Characterization of Acne Microbiota Before and After Treatment with a Topical Biotechnological Phytocomplex: Understanding Skin Dysbiosis
This study assessed the impact of a topical phytocomplex on the acne skin microbiota, encompassing bacterial, fungal, and phage communities. Skin samples obtained from participants exhibiting a positive response to the treatment were analyzed using high-throughput sequencing and bioinformatic approaches including taxonomic profiling, metagenome assembly, functional annotation, and phage identification. Results showed that after treatment, microbial diversity increased, reflecting a more balanced microbial composition. Cutibacterium acnes levels were reduced, particularly virulent IA1/IA2 phylotypes, whereas non-pathogenic or unclassified strains increased. Opportunistic pathogens such as Klebsiella pneumoniae were no longer detected, and beneficial genera including Psychrobacter and Dermabacter were enriched. Functional analysis showed reduced virulence- and biofilm-related pathways, alongside enhanced tryptophan metabolism, SCFA production, lipid synthesis, and riboflavin and folate biosynthesis. Fungal populations, dominated by Malassezia, became more evenly distributed, with notable post-treatment reductions in M. arunalokei, Exophiala spinifera, and Wickerhamomyces anomalus. Phage populations mirrored bacterial changes, with enrichment of Cutibacterium-associated phages post-treatment. These findings demonstrate that the phytocomplex promotes functional rebalancing of the skin microbiota by reducing pathogenic features while maintaining ecosystem stability. The inhibition of quorum sensing, potentially mediated by N-acyl-homoserine lactone acetylation, emerged from metabolic pathway annotation as a hypothetic key mechanism impairing bacterial communication and virulence associated with acne vulgaris.
- 18 April 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (4) , 915
Open AccessShotgun Metagenomic Characterization of Acne Microbiota Before and After Treatment with a Topical Biotechnological Phytocomplex: Understanding Skin Dysbiosis
This study assessed the impact of a topical phytocomplex on the acne skin microbiota, encompassing bacterial, fungal, and phage communities. Skin samples obtained from participants exhibiting a positive response to the treatment were analyzed using high-throughput sequencing and bioinformatic approaches including taxonomic profiling, metagenome assembly, functional annotation, and phage identification. Results showed that after treatment, microbial diversity increased, reflecting a more balanced microbial composition. Cutibacterium acnes levels were reduced, particularly virulent IA1/IA2 phylotypes, whereas non-pathogenic or unclassified strains increased. Opportunistic pathogens such as Klebsiella pneumoniae were no longer detected, and beneficial genera including Psychrobacter and Dermabacter were enriched. Functional analysis showed reduced virulence- and biofilm-related pathways, alongside enhanced tryptophan metabolism, SCFA production, lipid synthesis, and riboflavin and folate biosynthesis. Fungal populations, dominated by Malassezia, became more evenly distributed, with notable post-treatment reductions in M. arunalokei, Exophiala spinifera, and Wickerhamomyces anomalus. Phage populations mirrored bacterial changes, with enrichment of Cutibacterium-associated phages post-treatment. These findings demonstrate that the phytocomplex promotes functional rebalancing of the skin microbiota by reducing pathogenic features while maintaining ecosystem stability. The inhibition of quorum sensing, potentially mediated by N-acyl-homoserine lactone acetylation, emerged from metabolic pathway annotation as a hypothetic key mechanism impairing bacterial communication and virulence associated with acne vulgaris.
- Open Access
Efficacy and Safety of Novel 1% Hydrogen Peroxide Formulations for the Treatment of Mild-to-Moderate Facial and Truncal Acne Vulgaris
Acne vulgaris remains a common condition, with current topical therapies often limited by suboptimal efficacy and tolerability. This study evaluated the efficacy and safety of two novel 1% hydrogen peroxide (H2O2) formulations, a cream-gel for facial and a sprayable lotion for truncal mild-to-moderate acne. 42 participants presenting facial acne and 41 with truncal acne were treated twice daily for 8 weeks. Efficacy was assessed using the Investigator’s Global Assessment (IGA), the Spanish Acne Severity Scale (EGAE), and lesion counts. After 56 days, facial acne severity improved significantly (IGA −26%, p = 0.01; EGAE −31%, p = 0.01), with reductions in papules (−45%, p = 0.017), porphyrin count (−27%, p = 0.04), sebum production (−75%, p = 0.005), erythema (−35%, p = 0.0001), and desquamation (−22%, p = 0.02). Truncal acne severity also improved significantly (IGA −32%, p = 0.001; EGAE −45%, p = 0.001), with reductions in inflammatory lesions (−60%, p = 0.001), porphyrin size and count (−55% and −48%, both p = 0.001), erythema (−7%, p = 0.005), and desquamation (−27%, p = 0.001). Both formulations were accepted by the users, with minimal local irritation and high patient satisfaction. Topical 1% H2O2 formulations demonstrated significant and well-tolerated efficacy in both facial and truncal acne, supporting their potential as safe and patient-friendly options for managing mild-to-moderate acne.
Open AccessEfficacy and Safety of Novel 1% Hydrogen Peroxide Formulations for the Treatment of Mild-to-Moderate Facial and Truncal Acne Vulgaris
Acne vulgaris remains a common condition, with current topical therapies often limited by suboptimal efficacy and tolerability. This study evaluated the efficacy and safety of two novel 1% hydrogen peroxide (H2O2) formulations, a cream-gel for facial and a sprayable lotion for truncal mild-to-moderate acne. 42 participants presenting facial acne and 41 with truncal acne were treated twice daily for 8 weeks. Efficacy was assessed using the Investigator’s Global Assessment (IGA), the Spanish Acne Severity Scale (EGAE), and lesion counts. After 56 days, facial acne severity improved significantly (IGA −26%, p = 0.01; EGAE −31%, p = 0.01), with reductions in papules (−45%, p = 0.017), porphyrin count (−27%, p = 0.04), sebum production (−75%, p = 0.005), erythema (−35%, p = 0.0001), and desquamation (−22%, p = 0.02). Truncal acne severity also improved significantly (IGA −32%, p = 0.001; EGAE −45%, p = 0.001), with reductions in inflammatory lesions (−60%, p = 0.001), porphyrin size and count (−55% and −48%, both p = 0.001), erythema (−7%, p = 0.005), and desquamation (−27%, p = 0.001). Both formulations were accepted by the users, with minimal local irritation and high patient satisfaction. Topical 1% H2O2 formulations demonstrated significant and well-tolerated efficacy in both facial and truncal acne, supporting their potential as safe and patient-friendly options for managing mild-to-moderate acne.
- Open Access
- 21 January 2026
- Published by MDPI AG in Preprints.org
Efficacy and Safety of Novel 1% Hydrogen Peroxide Formulations for the Treatment of Mild to Moderate Facial and Truncal Acne Vulgaris
Acne vulgaris remains a common condition, with current topical therapies often limited by suboptimal efficacy and tolerability. This study evaluated the efficacy and safety of two novel 1% hydrogen peroxide (H₂O₂) formulations, a cream-gel for facial and a sprayable lotion for truncal mild to moderate acne. 42 participants presenting facial acne and 41 with truncal acne were treated twice daily for 8 weeks. Efficacy was assessed using the Investigator’s Global Assessment (IGA), the Spanish Acne Severity Scale (EGAE), and lesion counts. After 56 days, facial acne severity improved significantly (IGA −26%, p=0.01; EGAE −31%, p=0.01), with reductions in papules (−45%, p=0.017), porphyrin count (−27%, p=0.04), sebum production (−75%, p=0.005), erythema (−35%, p=0.0001), and desquamation (−22%, p=0.02). Truncal acne severity also improved sig-nificantly (IGA −32%, p=0.001; EGAE −45%, p=0.001), with reductions in inflammatory lesions (−60%, p=0.001), porphyrin size and count (-55% and −48%, both p=0.001), ery-thema (−7%, p=0.005), and desquamation (−27%, p=0.001). Both formulations were ac-cepted by the users, with minimal local irritation and high patient satisfaction. Topical 1% H₂O₂ formulations demonstrated significant and well-tolerated efficacy in both fa-cial and truncal acne, supporting their potential as safe and patient-friendly options for managing mild to moderate acne.
- 21 January 2026
- Published by MDPI AG in Preprints.org
Open AccessEfficacy and Safety of Novel 1% Hydrogen Peroxide Formulations for the Treatment of Mild to Moderate Facial and Truncal Acne Vulgaris
Acne vulgaris remains a common condition, with current topical therapies often limited by suboptimal efficacy and tolerability. This study evaluated the efficacy and safety of two novel 1% hydrogen peroxide (H₂O₂) formulations, a cream-gel for facial and a sprayable lotion for truncal mild to moderate acne. 42 participants presenting facial acne and 41 with truncal acne were treated twice daily for 8 weeks. Efficacy was assessed using the Investigator’s Global Assessment (IGA), the Spanish Acne Severity Scale (EGAE), and lesion counts. After 56 days, facial acne severity improved significantly (IGA −26%, p=0.01; EGAE −31%, p=0.01), with reductions in papules (−45%, p=0.017), porphyrin count (−27%, p=0.04), sebum production (−75%, p=0.005), erythema (−35%, p=0.0001), and desquamation (−22%, p=0.02). Truncal acne severity also improved sig-nificantly (IGA −32%, p=0.001; EGAE −45%, p=0.001), with reductions in inflammatory lesions (−60%, p=0.001), porphyrin size and count (-55% and −48%, both p=0.001), ery-thema (−7%, p=0.005), and desquamation (−27%, p=0.001). Both formulations were ac-cepted by the users, with minimal local irritation and high patient satisfaction. Topical 1% H₂O₂ formulations demonstrated significant and well-tolerated efficacy in both fa-cial and truncal acne, supporting their potential as safe and patient-friendly options for managing mild to moderate acne.
- Open Access
- 23 July 2024
- Published by Wiley in Skin Research and Technology
- Vol. 30 (7) , e13806
A new topical biotechnological phytocomplex for truncal mild‐moderate acne restores skin microbiota balance
Background: The disruption of the microbial community or dysbiosis alters the functional composition, metabolic activity, and local distribution of the microbiota leading the development of acne. The aim of this study is to evaluate the effect of a lotion containing a biotechnological phytocomplex, niacinamide, and succinic acid in the bacterial diversity of subjects with truncal mild‐moderate acne and its clinical benefits due to microbiota changes. Materials and Methods: Open, clinical study in 43 subjects with truncal mild‐moderate acne treated with a lotion for 8 weeks. Bacterial diversity was analyzed by 16S rRNA gene sequencing of skin samples. Clinical effects were evaluated through IGA acne severity scale, biometric measurements, and safety. Results: After 56 days of product's use, an increase in richness alpha diversity was found ( p = 0.005), with a decrease in Cutibacterium acnes relative abundance (66.43% vs. 58.11%, p = 0.009). The clinical results showed a decrease in IGA score (27.59% decrease; p = 0.001), the inflammatory lesions (52.12% decrease, p = 0.006) and erythema (18.33% decrease, p = 0.007), and desquamation index (63.83% decrease, p = 0.02). The responder analysis of the IGA score showed that 60.47% of patients improved by at least one point at day 56. The product was well tolerated along the study. Conclusion: The use of the lotion on acneic skin was effective on rebalancing the microbiota, inhibiting biofilm formation and other virulence factors, reducing erythema and desquamation, and improving acne's severity.
- 23 July 2024
- Published by Wiley in Skin Research and Technology
- Vol. 30 (7) , e13806
Open AccessA new topical biotechnological phytocomplex for truncal mild‐moderate acne restores skin microbiota balance
Background: The disruption of the microbial community or dysbiosis alters the functional composition, metabolic activity, and local distribution of the microbiota leading the development of acne. The aim of this study is to evaluate the effect of a lotion containing a biotechnological phytocomplex, niacinamide, and succinic acid in the bacterial diversity of subjects with truncal mild‐moderate acne and its clinical benefits due to microbiota changes. Materials and Methods: Open, clinical study in 43 subjects with truncal mild‐moderate acne treated with a lotion for 8 weeks. Bacterial diversity was analyzed by 16S rRNA gene sequencing of skin samples. Clinical effects were evaluated through IGA acne severity scale, biometric measurements, and safety. Results: After 56 days of product's use, an increase in richness alpha diversity was found ( p = 0.005), with a decrease in Cutibacterium acnes relative abundance (66.43% vs. 58.11%, p = 0.009). The clinical results showed a decrease in IGA score (27.59% decrease; p = 0.001), the inflammatory lesions (52.12% decrease, p = 0.006) and erythema (18.33% decrease, p = 0.007), and desquamation index (63.83% decrease, p = 0.02). The responder analysis of the IGA score showed that 60.47% of patients improved by at least one point at day 56. The product was well tolerated along the study. Conclusion: The use of the lotion on acneic skin was effective on rebalancing the microbiota, inhibiting biofilm formation and other virulence factors, reducing erythema and desquamation, and improving acne's severity.
- Open Access
- 29 March 2021
- Published by Editorial Biotecnologica S.R.L. in Dermatología Argentina
- Vol. 25 (1) , 20-24
Melanomas de diámetro pequeño: papel de la dermatoscopia y seguimiento con dermatoscopia digital
Antecedentes: El reconocimiento de melanomas de pequeño diámetro (MPD) a menudo plantea un desafío Objetivos: Analizar el rol de la dermatoscopía y el seguimiento con dermatoscopía digital en el diagnostico de MPD Diseño: Análisis retrospectivo, observacional, descriptivo de una serie de 50 MPD diagnosticados entre 2015 y 2019. Resultados: Entre los MPD, 9 fueron motivo de consulta del paciente (MMC), 30 se detectaron durante el control rutinario de nevos (MMCR) y 11 fueron diagnosticados por cambios observados durante el seguimiento con dermatoscopía digital (MMDD). Cerca del 45% de los MMC fueron clasificados correctamente como lesiones malignas según la “regla ABCD de dermatoscopía”; esto se observó sólo en el 20% de los MMCR y en ninguno de las MMDD. El algoritmo “caos y pistas” condujo a la extirpación en casi el 90% de los MMC, el 60% de los MMCR y el 50% de los MMDD. Los porcentajes de melanoma in situfueron: 55% entre los MMC, 73,3% entre los MMCR y 72,9% entre los MMDD. En los melanomas invasivos, el grosor de Breslow medio fue de 0,62 mm en el grupo MMC, 0,5 mm en el MMCCR y 0,4 mm en el MMDD Conclusiones: El uso rutinario de la dermatoscopía permite la detección de melanomas con bajo índice de sospecha que los pacientes podrían desconocer. El uso del seguimiento digital permite la detección de melanomas incipientes que carecen no sólo de criterios clínicos sino también dermatoscópicos de malignidad.
- 29 March 2021
- Published by Editorial Biotecnologica S.R.L. in Dermatología Argentina
- Vol. 25 (1) , 20-24
Open AccessMelanomas de diámetro pequeño: papel de la dermatoscopia y seguimiento con dermatoscopia digital
Antecedentes: El reconocimiento de melanomas de pequeño diámetro (MPD) a menudo plantea un desafío Objetivos: Analizar el rol de la dermatoscopía y el seguimiento con dermatoscopía digital en el diagnostico de MPD Diseño: Análisis retrospectivo, observacional, descriptivo de una serie de 50 MPD diagnosticados entre 2015 y 2019. Resultados: Entre los MPD, 9 fueron motivo de consulta del paciente (MMC), 30 se detectaron durante el control rutinario de nevos (MMCR) y 11 fueron diagnosticados por cambios observados durante el seguimiento con dermatoscopía digital (MMDD). Cerca del 45% de los MMC fueron clasificados correctamente como lesiones malignas según la “regla ABCD de dermatoscopía”; esto se observó sólo en el 20% de los MMCR y en ninguno de las MMDD. El algoritmo “caos y pistas” condujo a la extirpación en casi el 90% de los MMC, el 60% de los MMCR y el 50% de los MMDD. Los porcentajes de melanoma in situfueron: 55% entre los MMC, 73,3% entre los MMCR y 72,9% entre los MMDD. En los melanomas invasivos, el grosor de Breslow medio fue de 0,62 mm en el grupo MMC, 0,5 mm en el MMCCR y 0,4 mm en el MMDD Conclusiones: El uso rutinario de la dermatoscopía permite la detección de melanomas con bajo índice de sospecha que los pacientes podrían desconocer. El uso del seguimiento digital permite la detección de melanomas incipientes que carecen no sólo de criterios clínicos sino también dermatoscópicos de malignidad.